These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33686135)

  • 1. Homotaurine limits the spreading of T cell autoreactivity within the CNS and ameliorates disease in a model of multiple sclerosis.
    Tian J; Song M; Kaufman DL
    Sci Rep; 2021 Mar; 11(1):5402. PubMed ID: 33686135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homotaurine, a safe blood-brain barrier permeable GABA
    Tian J; Dang H; Wallner M; Olsen R; Kaufman DL
    Sci Rep; 2018 Nov; 8(1):16555. PubMed ID: 30410049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis.
    Tuohy VK; Yu M; Yin L; Kawczak JA; Kinkel RP
    J Exp Med; 1999 Apr; 189(7):1033-42. PubMed ID: 10190894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice.
    Katz-Levy Y; Neville KL; Girvin AM; Vanderlugt CL; Pope JG; Tan LJ; Miller SD
    J Clin Invest; 1999 Sep; 104(5):599-610. PubMed ID: 10487774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis.
    Howard LM; Miga AJ; Vanderlugt CL; Dal Canto MC; Laman JD; Noelle RJ; Miller SD
    J Clin Invest; 1999 Jan; 103(2):281-90. PubMed ID: 9916140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread.
    Takács K; Chandler P; Altmann DM
    Eur J Immunol; 1997 Nov; 27(11):2927-34. PubMed ID: 9394820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
    Rostami A; Ciric B
    J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis.
    McMahon EJ; Bailey SL; Castenada CV; Waldner H; Miller SD
    Nat Med; 2005 Mar; 11(3):335-9. PubMed ID: 15735651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tertiary lymphoid organ development coincides with determinant spreading of the myelin-specific T cell response.
    Kuerten S; Schickel A; Kerkloh C; Recks MS; Addicks K; Ruddle NH; Lehmann PV
    Acta Neuropathol; 2012 Dec; 124(6):861-73. PubMed ID: 22842876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS.
    Kong W; Li H; Tuma RF; Ganea D
    Cell Immunol; 2014 Jan; 287(1):1-17. PubMed ID: 24342422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen presentation in the CNS by myeloid dendritic cells drives progression of relapsing experimental autoimmune encephalomyelitis.
    Miller SD; McMahon EJ; Schreiner B; Bailey SL
    Ann N Y Acad Sci; 2007 Apr; 1103():179-91. PubMed ID: 17376826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of treatment with a small-molecule VLA-4 antagonist before and after onset of relapsing EAE.
    Theien BE; Vanderlugt CL; Nickerson-Nutter C; Cornebise M; Scott DM; Perper SJ; Whalley ET; Miller SD
    Blood; 2003 Dec; 102(13):4464-71. PubMed ID: 12933585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis.
    Tompkins SM; Padilla J; Dal Canto MC; Ting JP; Van Kaer L; Miller SD
    J Immunol; 2002 Apr; 168(8):4173-83. PubMed ID: 11937578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
    Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
    Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression and spreading of self-recognition during the development of autoimmune demyelinating disease.
    Tuohy VK; Yu M; Yin L; Kawczak JA; Kinkel PR
    J Autoimmun; 1999 Aug; 13(1):11-20. PubMed ID: 10441163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope spreading is not required for relapses in experimental autoimmune encephalomyelitis.
    Jones RE; Bourdette D; Moes N; Vandenbark A; Zamora A; Offner H
    J Immunol; 2003 Feb; 170(4):1690-8. PubMed ID: 12574332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.
    Vanderlugt CL; Neville KL; Nikcevich KM; Eagar TN; Bluestone JA; Miller SD
    J Immunol; 2000 Jan; 164(2):670-8. PubMed ID: 10623809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CD52 antibody treatment depletes B cell aggregates in the central nervous system in a mouse model of multiple sclerosis.
    Simon M; Ipek R; Homola GA; Rovituso DM; Schampel A; Kleinschnitz C; Kuerten S
    J Neuroinflammation; 2018 Aug; 15(1):225. PubMed ID: 30098594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
    Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
    Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.
    Becquet L; Abad C; Leclercq M; Miel C; Jean L; Riou G; Couvineau A; Boyer O; Tan YV
    J Neuroinflammation; 2019 Mar; 16(1):64. PubMed ID: 30894198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.